As of 2025-09-17, the Fair Value of Spruce Biosciences Inc (SPRB) is -4.94 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.58 USD, the upside of Spruce Biosciences Inc is -151.56%.
With the market price of 9.58 USD and our fair value calculation, Spruce Biosciences Inc (SPRB) is not a good investment. Investing in SPRB stocks now will result in a potential loss of 151.56%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -29.54 | -42.29 | -46.18 | -47.92 | -53.04 | -43.79 |
| YoY growth | -125.67% | -43.16% | -9.20% | -3.77% | -10.68% | -38.49% |
| Market Cap (mil) | 4.13 |
| P/E | |
| Forward P/E |
| EPS | -0.99 |
| Avg earnings growth rate | -38.49% |
| TTM earnings | -53.04 |